HomeCompareWXXWY vs EPRT

WXXWY vs EPRT: Dividend Comparison 2026

WXXWY yields 22.47% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WXXWY wins by $20.6K in total portfolio value
10 years
WXXWY
WXXWY
● Live price
22.47%
Share price
$8.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84.9K
Annual income
$8,701.95
Full WXXWY calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — WXXWY vs EPRT

📍 WXXWY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWXXWYEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WXXWY + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WXXWY pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WXXWY
Annual income on $10K today (after 15% tax)
$1,910.11/yr
After 10yr DRIP, annual income (after tax)
$7,396.66/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, EPRT beats the other by $3,798.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WXXWY + EPRT for your $10,000?

WXXWY: 50%EPRT: 50%
100% EPRT50/50100% WXXWY
Portfolio after 10yr
$74.6K
Annual income
$10,936.40/yr
Blended yield
14.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

WXXWY
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
8.1
Piotroski
8/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WXXWY buys
0
EPRT buys
0
No recent congressional trades found for WXXWY or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWXXWYEPRT
Forward yield22.47%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$84.9K$64.3K
Annual income after 10y$8,701.95$13,170.85
Total dividends collected$51.1K$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: WXXWY vs EPRT ($10,000, DRIP)

YearWXXWY PortfolioWXXWY Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$12,947$2,247.19$11,212$512.01+$1.7KWXXWY
2$16,573$2,719.14$12,689$692.09+$3.9KWXXWY
3$20,986$3,252.85$14,521$944.30+$6.5KWXXWY
4$26,304$3,849.55$16,841$1,302.88+$9.5KWXXWY
5$32,655$4,509.50$19,841$1,821.64+$12.8KWXXWY
6$40,173$5,232.02$23,818$2,587.47+$16.4KWXXWY
7$49,000$6,015.46$29,230$3,744.65+$19.8KWXXWY
8$59,288$6,857.29$36,816$5,540.38+$22.5KWXXWY
9$71,192$7,754.14$47,806$8,413.17+$23.4KWXXWY
10$84,877$8,701.95$64,324$13,170.85+$20.6KWXXWY

WXXWY vs EPRT: Complete Analysis 2026

WXXWYStock

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Full WXXWY Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this WXXWY vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WXXWY vs SCHDWXXWY vs JEPIWXXWY vs OWXXWY vs KOWXXWY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.